RAF-MEK-ERK pathway in cancer evolution and treatment

R Ullah, Q Yin, AH Snell, L Wan - Seminars in cancer biology, 2022 - Elsevier
Abstract The RAF-MEK-ERK signaling cascade is a well-characterized MAPK pathway
involved in cell proliferation and survival. The three-layered MAPK signaling cascade is …

Selective and noncovalent targeting of RAS mutants for inhibition and degradation

KW Teng, ST Tsai, T Hattori, C Fedele, A Koide… - Nature …, 2021 - nature.com
Activating mutants of RAS are commonly found in human cancers, but to date selective
targeting of RAS in the clinic has been limited to KRAS (G12C) through covalent inhibitors …

Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth

SM Shin, JS Kim, SW Park, SY Jun, HJ Kweon… - Science …, 2020 - science.org
Oncogenic RAS mutant (RASMUT) proteins have been considered undruggable via
conventional antibody regimens owing to the intracellular location restricting conventional …

[HTML][HTML] Targeting Ras with protein engineering

A Tomazini, JM Shifman - Oncotarget, 2023 - ncbi.nlm.nih.gov
Ras proteins are small GTPases that regulate cell growth and division. Mutations in Ras
genes are associated with many types of cancer, making them attractive targets for cancer …

Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS binders

YC Li, NK Lytle, ST Gammon, L Wang… - Proceedings of the …, 2020 - National Acad Sciences
HRAS, NRAS, and KRAS4A/KRAS4B comprise the RAS family of small GTPases that
regulate signaling pathways controlling cell proliferation, differentiation, and survival. RAS …

Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids

S Wiechmann, P Maisonneuve, BM Grebbin… - Journal of Biological …, 2020 - ASBMB
The small GTPases H, K, and NRAS are molecular switches indispensable for proper
regulation of cellular proliferation and growth. Several mutations in the genes encoding …

Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis

H Li, L Liu, J Zhuang, C Liu, C Zhou… - … Genetics & Genomic …, 2019 - Wiley Online Library
Background Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm that
arises from the acquisition of constitutively active BCR‐ABL tyrosine kinase in hematopoietic …

Protein-based Degrader Strategies against Oncogenic RAS

KM Cheah - 2023 - dspace.mit.edu
Targeted therapies have emerged as a promising cancer treatment strategy by inhibiting
proteins specific to cancer cells while preserving healthy cells. RAS proteins play a crucial …

[PDF][PDF] Competitive Inhibitors of Ras Effector Binding

S Wiechmann, P Maisonneuve, BM Grebbin… - Perspective, 2016 - researchgate.net
The small GTPases H, K and NRas are molecular switches that are indispensable for the
correct regulation of cellular proliferation and growth. Mutations in Ras are associated with …

Novel conformation specific inhibitors of activated GTPases reveal Ras-dependency of patient-derived cancer organoids

S Wiechmann, P Maisonneuve, BM Grebbin… - bioRxiv, 2019 - biorxiv.org
Abstract The small GTPases H, K, and NRAS are molecular switches that are indispensable
for proper regulation of cellular proliferation and growth. Mutations in this family of proteins …